HIV remains a persistent public health challenge in the United States. While infection rates have steadily declined over the ...

Despite being effective, PrEP uptake in Europe remains low due to issues like cost, access, and stigma, hindering its ...

which shows the demand in the market for alternatives to daily oral PrEP. PrEP – generally used by at-risk people such as an HIV-negative individual with an HIV-positive partner – requires ...

Human immunodeficiency virus, if untreated, causes acquired immunodeficiency syndrome (AIDS), and death. HIV is almost entirely preventable by using condoms, or by taking PrEP drugs. PrEP drugs do not ...

Social barriers were linked to reduced access and low uptake of LAI PrEP and ART for HIV treatment and prevention.

The FDA said that PrEP – used to protect at-risk people such as an HIV-negative individual with ... which suggests it is expecting high demand for the injectable alternative.

After a group of employers refused to provide their employees access to free HIV prevention treatment, the Supreme Court may ...

First Nations and Inuit are now covered to receive the HIV prevention drug Apretude, which is 99 per cent effective according to research.